Skip to content

Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01609621
Enrollment
199
Registered
2012-06-01
Start date
2012-05-31
Completion date
2013-08-31
Last updated
2020-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Limb Ischemia, Peripheral Arterial Disease

Brief summary

The objective of this prospective, non-randomized, multicenter, post-market, observational study is to compile clinical data on percutaneous techniques used to obtain tibiopedal access and to cross infrainguinal arterial occlusions.

Interventions

DEVICERetrograde tibiopedal arterial access

Retrograde, percutaneous arterial access of vessels at or below the tibioperoneal trunk, using a 21 gage needle or micropuncture introducer set, to facilitate crossing and treatment (e.g., angioplasty, stenting, atherectomy) of occlusive arterial lesions in the lower limb.

Sponsors

Cook Group Incorporated
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patient has a totally occluded infrainguinal artery, due to peripheral arterial atherosclerotic disease, for which a previous attempt to cross the occlusion using an antegrade approach was unsuccessful. For institutions where tibiopedal access is performed as a primary standard-of-care procedure, a prior unsuccessful antegrade approach attempt is not required.

Exclusion criteria

* Patient will not sign the Informed Consent

Design outcomes

Primary

MeasureTime frame
Technical Success deeming tibial pedal arterial access1 - 4 hours post-procedure.

Countries

Germany, Italy, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026